Schaefer B - Search Results

1

Specific inhibition of AKT2 by RNA interference results in reduction of ovarian cancer cell proliferation: increased expression of AKT in advanced ovarian cancer.

Noske A, Kaszubiak A, Weichert W, Sers C, Niesporek S, Koch I, Schaefer B, Sehouli J, Dietel M, Lage H, Denkert C. Noske A, et al. Among authors: schaefer b. Cancer Lett. 2007 Feb 8;246(1-2):190-200. doi: 10.1016/j.canlet.2006.02.018. Epub 2006 Apr 3. Cancer Lett. 2007. PMID: 16584837

2

Intracellular localization, vesicular accumulation and kinetics of daunorubicin in sensitive and multidrug-resistant gastric carcinoma EPG85-257 cells.

Seidel A, Hasmann M, Löser R, Bunge A, Schaefer B, Herzig I, Steidtmann K, Dietel M. Seidel A, et al. Among authors: schaefer b. Virchows Arch. 1995;426(3):249-56. doi: 10.1007/BF00191362. Virchows Arch. 1995. PMID: 7773504

3

Secondary combined resistance to the multidrug-resistance-reversing activity of cyclosporin A in the cell line F4-6RADR-CsA.

Dietel M, Herzig I, Reymann A, Brandt I, Schaefer B, Bunge A, Heidebrecht HJ, Seidel A. Dietel M, et al. Among authors: schaefer b. J Cancer Res Clin Oncol. 1994;120(5):263-71. doi: 10.1007/BF01236382. J Cancer Res Clin Oncol. 1994. PMID: 7907333

4

In vitro prediction of cytostatic drug resistance in primary cell cultures of solid malignant tumours.

Dietel M, Bals U, Schaefer B, Herzig I, Arps H, Zabel M. Dietel M, et al. Among authors: schaefer b. Eur J Cancer. 1993;29A(3):416-20. doi: 10.1016/0959-8049(93)90398-y. Eur J Cancer. 1993. PMID: 8398343

5

alpha 2-Antiplasmin and plasminogen activator inhibitors in healing human skin wounds.

Schaefer BM, Maier K, Eickhoff U, Bechtel M, Kramer MD. Schaefer BM, et al. Arch Dermatol Res. 1996 Mar;288(3):122-8. doi: 10.1007/BF02505820. Arch Dermatol Res. 1996. PMID: 8967779

6

Plasminogen activator inhibitor type-2 (PAI-2) in human keratinocytes regulates pericellular urokinase-type plasminogen activator.

Reinartz J, Schaefer B, Bechtel MJ, Kramer MD. Reinartz J, et al. Among authors: schaefer b. Exp Cell Res. 1996 Feb 25;223(1):91-101. doi: 10.1006/excr.1996.0061. Exp Cell Res. 1996. PMID: 8635500

7

Plasminogen activation by human keratinocytes: molecular pathways and cell-biological consequences.

Kramer MD, Schaefer B, Reinartz J. Kramer MD, et al. Among authors: schaefer b. Biol Chem Hoppe Seyler. 1995 Mar;376(3):131-41. doi: 10.1515/bchm3.1995.376.3.131. Biol Chem Hoppe Seyler. 1995. PMID: 7612190 Review.

8

Plasminogen activator inhibitor type-2 in the lesional epidermis of lupus erythematosus.

Bechtel MJ, Schaefer BM, Kramer MD. Bechtel MJ, et al. Among authors: schaefer bm. Br J Dermatol. 1996 Mar;134(3):411-9. Br J Dermatol. 1996. PMID: 8731662

9

Plasminogen activation in bullous pemphigoid immunohistology reveals urokinase type plasminogen activator, its receptor and plasminogen activator inhibitor type-2 in lesional epidermis.

Schaefer BM, Jaeger C, Drepper E, Kramer MD. Schaefer BM, et al. Autoimmunity. 1996;23(3):155-64. doi: 10.3109/08916939608995339. Autoimmunity. 1996. PMID: 8879451 Free article.

10

Dispase-mediated basal detachment of cultured keratinocytes induces urokinase-type plasminogen activator (uPA) and its receptor (uPA-R, CD87).

Schaefer BM, Reinartz J, Bechtel MJ, Inndorf S, Lang E, Kramer MD. Schaefer BM, et al. Exp Cell Res. 1996 Nov 1;228(2):246-53. doi: 10.1006/excr.1996.0323. Exp Cell Res. 1996. PMID: 8912717

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

482 results

Search Page

Filters